While the healthcare ETFs like the iShares Nasdaq Biotechnology ETF (IBB) are pulling back slightly this morning, mainly due to Amgen declining today, despite beating its earnings estimates and raising its full-year guidance, the overall healthcare sector is a top performer for October. AMGN...